A New Solution to Quit Smoking


Smokers in the US


E-Cigs in the US

Nicotine Addiction Is Not a Problem of the Past

Smoking is still a global public health threat and despite having medication for decades, we’ve yet to eradicate this global epidemic.


of cancer deaths in the U.S. are attributed to cigarette smoking


U.S. Deaths Nationwide


Americans Live with Smoking- Related Disease

Let’s face it. Current treatments are failing. We’re here to change that.

While the majority of people who smoke in the US say they would like to quit and more than half make an attempt, only a tiny percentage of quit attempts are successful. No new smoking cessation treatments have been FDA approved since 2006. With only two non-nicotine FDA-approved smoking cessation treatments, there are still no approved treatments specifically for e-cigarette smoking cessation.



Derived from natural sources, including the seeds of the laburnum tree, cytisinicline is a potential new treatment for smoking cessation and nicotine addiction.

Helping smokers quit… with minimal side effects

In a recent trial, cytisinicline has been shown to effectively help even highly dependent smokers stop smoking. Cytisinicline binds to the same receptors as nicotine to reduce both withdrawal symptoms and satisfaction associated with smoking. And since it doesn’t bind as strongly to certain receptors, it is believed to have less potential to cause side effects—including nausea and vomiting.


Trial participants had over 90% compliance with cytisinicline treatment

About Achieve

Achieve is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction.



Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

Company to host conference call at 4:30 PM EST today, Thursday, November 9, 2023 SEATTLE, Wash and VANCOUVER, British Co

Read More

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

SEATTLE, WA and VANCOUVER, British Columbia, October 26, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ:

Read More

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, October 3, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: A

Read More

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: AC

Read More

We can’t help but


And we’re looking for others like us who believe we can bring an end to this fight.
Will you join us?

  • US Headquarters
  • 22722 29th Dr SE, Suite 100
  • Bothell, WA 98021
  • Phone: (425) 686-1500
  • Vancouver Office
  • 1040 W Georgia Street, Suite 1030
  • Vancouver, BC V6E 4H1